Literature DB >> 36071310

A Novel Thermal-driven Self-assembly Method to Prepare Albumin Nanoparticles: Formation Kinetics, Degradation Behavior and Formation Mechanism.

Fang Li1, Stacy Yeh2, Qin Shi3, Peng Wang4, Hongyan Wu3, Junbo Xin5.   

Abstract

Nanoparticles based on bovine serum albumin (BSA), which shares 76% homology with human serum albumin (HSA), have emerged as a promising candidate for the efficient delivery of anticancer drugs. Thermal-driven self-assembly is a novel organic solvent-free approach to produce albumin nanoparticles. In our previous study, some features of this nanoparticle such as drug loading efficiency, drug encapsulation efficiency and drug release kinetics have been evaluated. However, the formation mechanism that determines the above nanoparticle properties remains unclear. Here, we investigated the formation kinetics and mechanism using spectroscopic methods including fluorescence spectroscopy, circular dichroism (CD) and differential scanning calorimetry (DSC). We also applied chemical analysis methods that measured the content changes of albumin active groups and vanillin. To verify the covalent networks in the nanoparticles, trypsin and glutathione (GSH) were used separately to cleave the peptide bonds and disulfide bridges, and dynamic light scattering (DLS) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were used to analyze the degraded samples. BSA nanoparticles started to form at 10 min and were completely formed at 120 min. With the digestion of trypsin, more than 50% of the nanoparticles were degraded within 60 min. CD spectra showed that α-helical structure of BSA decreased from 42.3% to 39.8% and 37.7% after heating for 10 and 60 min, respectively. In the DSC thermogram, the melting peak of BSA nanoparticles was 229.14℃, which is about 12℃ higher than the physical mixture of BSA and vanillin, indicating that chemical reactions occurred during the nanoparticle formation and formed a new more stable substance. Moreover, the results of active group assay, GSH degradation and SDS-PAGE experiments also proved that disulfide bonds and peptide bonds were formed between BSA molecules, whereas Schiff bases were formed between BSA and vanillin molecules. Formation kinetics and degradation behavior are important properties to characterize albumin nanoparticles and should be paid attention to. Not only that, this study also provides an effective way to study the formation mechanism of protein-based nanodrug delivery systems.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  albumin nanoparticles; degradation behavior; formation kinetics; formation mechanism; thermal-driven self-assembly

Mesh:

Substances:

Year:  2022        PMID: 36071310     DOI: 10.1208/s12249-022-02407-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   4.026


  44 in total

Review 1.  Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence.

Authors:  Diego Adrianzen Herrera; Nadia Ashai; Roman Perez-Soler; Haiying Cheng
Journal:  Expert Opin Pharmacother       Date:  2018-11-15       Impact factor: 3.889

2.  Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer.

Authors:  Yuko Kawano; Tomonari Sasaki; Hiroyuki Yamaguchi; Katsuya Hirano; Atsushi Horiike; Miyako Satouchi; Shinobu Hosokawa; Ryotaro Morinaga; Kazutoshi Komiya; Koji Inoue; Yuka Fujita; Ryo Toyozawa; Tomoki Kimura; Kosuke Takahashi; Kazuo Nishikawa; Junji Kishimoto; Yoichi Nakanishi; Isamu Okamoto
Journal:  Lung Cancer       Date:  2018-09-18       Impact factor: 5.705

3.  Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.

Authors:  Anne-Laure Pointet; David Tougeron; Simon Pernot; Astrid Pozet; Dominique Béchade; Isabelle Trouilloud; Nelson Lourenco; Vincent Hautefeuille; Christophe Locher; Nicolas Williet; Jérôme Desrame; Pascal Artru; Emilie Soularue; Bertrand Le Roy; Julien Taieb
Journal:  Clin Res Hepatol Gastroenterol       Date:  2019-10-10       Impact factor: 2.947

Review 4.  Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts.

Authors:  G Arpino; F Marmé; J Cortés; E Ricevuto; R Leonard; A Llombart-Cussac
Journal:  Crit Rev Oncol Hematol       Date:  2015-10-28       Impact factor: 6.312

Review 5.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

6.  Doxorubicin-loaded, pH-sensitive Albumin Nanoparticles for Lung Cancer Cell Targeting.

Authors:  Ahmed Aziz; Yahya Sefidbakht; Shokouh Rezaei; Hasan Kouchakzadeh; Vuk Uskoković
Journal:  J Pharm Sci       Date:  2021-12-09       Impact factor: 3.534

7.  Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Authors:  Dawei Ding; Xiaolei Tang; Xiaoli Cao; Jinhui Wu; Ahu Yuan; Qian Qiao; Jing Pan; Yiqiao Hu
Journal:  AAPS PharmSciTech       Date:  2013-11-28       Impact factor: 3.246

8.  Effective Anticancer Therapy by Combination of Nanoparticles Encapsulating Chemotherapeutic Agents and Weak Electric Current.

Authors:  Anowara Khatun; Mahadi Hasan; Mahran Mohamed Abd El-Emam; Tatsuya Fukuta; Miyuki Mimura; Riho Tashima; Shintaro Yoneda; Shintaro Yoshimi; Kentaro Kogure
Journal:  Biol Pharm Bull       Date:  2022       Impact factor: 2.233

9.  The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis.

Authors:  Caihua Liang; Ling Li; Cindy Duval Fraser; Amy Ko; Deyanira Corzo; Cheryl Enger; Debra Patt
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

10.  Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.

Authors:  Fang Li; Chunli Zheng; Junbo Xin; Fangcheng Chen; Hua Ling; Linlin Sun; Thomas J Webster; Xin Ming; Jianping Liu
Journal:  Int J Nanomedicine       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.